Detalhe da pesquisa
1.
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
Blood
; 139(17): 2706-2711, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134127
2.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Blood
; 140(1): 16-24, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325065
3.
Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy.
Cytotherapy
; 26(3): 261-265, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149948
4.
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Blood
; 137(19): 2585-2597, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270816
5.
CAR T cells and autologous transplantation can coexist for DLBCL.
Blood
; 139(9): 1266-1267, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238887
6.
COVID-specific T's may offset therapeutically endangered B's.
Blood
; 139(1): 12-13, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989773
7.
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma.
Clin Adv Hematol Oncol
; 16(5): 375-386, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29851933
8.
Emerging Challenges to Cellular Therapy of Cancer.
Cancer J
; 29(1): 20-27, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693154
9.
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.
J Clin Oncol
; 39(13): 1415-1425, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507803
10.
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.
Sci Transl Med
; 12(554)2020 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727914
11.
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
J Clin Oncol
; 38(32): 3794-3804, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32701411
12.
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
Cancer J
; 25(3): 199-207, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31135527
13.
Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib.
J Gastrointest Cancer
; 44(1): 98-101, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054578